The development of drugs to treat some of the world’s most deadly viruses is a primary area of focus by the pharmaceutical community during the last 20 years. There are dozens of antiviral drugs currently approved for use and many times more in development. The ability to easily and quickly follow the impact of a given therapy on viral concentration provides significant advantages over traditional approaches that slow down the pace of research by days or weeks. To learn more, email us at email@example.com.
White Papers & Case Studies
“It is enough for me to say that using the Virus Counter was effective in replacing 2 hours of work and 6 days of waiting for results with only 30 minutes to 1 hour to get a conclusive result. The Virus Counter has had and will have a great impact on our work stream, specifically when results are needed right away to start the next step of the experiment.”
—Protein Sciences Corporation